These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5597204)

  • 1. [Inhibition of monoamine oxidase activity by 2-N-acetylaminocyclohexene-2-one and related compounds].
    Ermolaev KM; Gridneva LI; Maĭmind VI; Gorkin VZ
    Vopr Med Khim; 1967; 13(3):286-90. PubMed ID: 5597204
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors].
    Severina IS
    Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599
    [No Abstract]   [Full Text] [Related]  

  • 3. INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES.
    FULLER RW; WALTERS CP
    Biochem Pharmacol; 1965 Feb; 14():159-63. PubMed ID: 14332461
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the mechanism of the effect of higher fatty acids on mitochondrial monoamine oxidase activity].
    Rapava EA; Kliashtorin LB; Gorkin VZ
    Biokhimiia; 1966; 31(6):1216-24. PubMed ID: 5999850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sulfhydryl groups in mitochondrial monoamine oxidase activity].
    Kliashtorin LB; Gridneva LI
    Biokhimiia; 1966; 31(4):831-9. PubMed ID: 5999967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the structure of the substrate and the activity of mitochondrial monoamine oxidase].
    Severina IS; Sheremet'evskaia TN
    Biokhimiia; 1969; 34(1):125-35. PubMed ID: 5801313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INHIBITION OF PLASMA MONOAMINE OXIDASE BY CYSTEAMINE.
    DEMARCO C; COLETTA M; BOMBARDIERI G
    Nature; 1965 Jan; 205():176. PubMed ID: 14276267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of some derivatives of piperidine, piperazine and related compounds on deamination of serotonin, tyramine and benzylamine by pig liver mitochondrial monoamine oxidase].
    Prikulis AA; Grinberga BA; Grinshteĭn VIa; Strelka GR
    Biokhimiia; 1983; 48(2):313-9. PubMed ID: 6838929
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity relationship studies of neuronal monoamine uptake inhibition of pyridylallylamines.
    Singh P
    Indian J Biochem Biophys; 1984 Dec; 21(6):406-8. PubMed ID: 6545533
    [No Abstract]   [Full Text] [Related]  

  • 14. MAOIs and food-fact and fiction.
    Stewart MM
    J Hum Nutr; 1976 Dec; 30(6):415-9. PubMed ID: 1029755
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL; Ascher JA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.
    Yoshida S; Meyer OG; Rosen TC; Haufe G; Ye S; Sloan MJ; Kirk KL
    J Med Chem; 2004 Mar; 47(7):1796-806. PubMed ID: 15027872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in studies on the specific inhibition and nature of monoamine oxidases (review)].
    Gorkin VZ
    Vopr Med Khim; 1982; 28(2):2-9. PubMed ID: 6805132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.